Literature DB >> 3121789

Neuritic plaque amyloid in Alzheimer's disease is highly racemized.

R Shapira1, G E Austin, S S Mirra.   

Abstract

Neuritic plaque core amyloid protein in Alzheimer's disease brain tissue was investigated for the extent of amino acid racemization. Long-lived human proteins exhibit racemization of certain amino acids over the course of a human lifetime. Purified core amyloid was found to contain relatively large proportions of D-aspartate and D-serine, suggesting that neuritic plaque amyloid is derived from a long-lived precursor protein. Alternatively, racemization of protein amino acids may be abnormally accelerated in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3121789     DOI: 10.1111/j.1471-4159.1988.tb13231.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

Review 1.  The molecular pathology of amyloid deposition in Alzheimer's disease.

Authors:  R N Martins; P J Robinson; J O Chleboun; K Beyreuther; C L Masters
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

2.  D-Aspartyl residue in a peptide can be liberated and metabolized by pig kidney enzymes.

Authors:  Y Kera; K Funabashi; T Matsumoto; T Watanabe; H Nagasaki; R Yamada
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

3.  Aggregation and disaggregation of senile plaques in Alzheimer disease.

Authors:  L Cruz; B Urbanc; S V Buldyrev; R Christie; T Gómez-Isla; S Havlin; M McNamara; H E Stanley; B T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

4.  Interaction of synthetic Alzheimer beta-protein-derived analogs with aqueous aluminum: a low-field 27Al NMR investigation.

Authors:  S B Vyas; L K Duffy
Journal:  J Protein Chem       Date:  1995-11

Review 5.  Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.

Authors:  C Glabe
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

6.  Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's Disease.

Authors:  Evan E Hubbard; Lilian R Heil; Gennifer E Merrihew; Jasmeer P Chhatwal; Martin R Farlow; Catriona A McLean; Bernardino Ghetti; Kathy L Newell; Matthew P Frosch; Randall J Bateman; Eric B Larson; C Dirk Keene; Richard J Perrin; Thomas J Montine; Michael J MacCoss; Ryan R Julian
Journal:  J Proteome Res       Date:  2021-11-24       Impact factor: 4.466

7.  Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation.

Authors:  Katrin Bigl; Frank Gaunitz; Annett Schmitt; Sven Rothemund; Reinhard Schliebs; Gerald Münch; Thomas Arendt
Journal:  J Neural Transm (Vienna)       Date:  2008-09-30       Impact factor: 3.575

8.  Altered aspartate in Alzheimer neurofibrillary tangles.

Authors:  I L Payan; S J Chou; G H Fisher; E H Man; C Emory; W H Frey
Journal:  Neurochem Res       Date:  1992-02       Impact factor: 3.996

Review 9.  The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses.

Authors:  Laura Morelli; Ramiro Llovera; Sandra Ibendahl; Eduardo M Castaño
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

10.  Age-dependent racemization of serine residues in a human chaperone protein.

Authors:  Michelle Y S Hooi; Mark J Raftery; Roger J W Truscott
Journal:  Protein Sci       Date:  2013-01       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.